Disclosure 0001916048-26-000012-2

SEC FORM 4

$193,188.72

Mineralys Therapeutics, Inc. (MLYS)

Sale of 7,437 shares at $25.9767 per share.

Reporting Person Warren Eric · Officer Title Chief Commercial Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001916048-26-000012 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Mineralys Therapeutics, Inc. (MLYS)." Disclosed 2026-08-25. https://desqlong.com/cards/0001916048-26-000012-2 (retrieved 2026-09-26).